ONC - BeiGene targets $4.9B-$5.3B revenue for 2025 with strong BRUKINSA and pipeline growth
2025-05-07 14:05:03 ET
More on BeiGene, Ltd., BeiGene, etc.
- BeiGene, Ltd. (ONC) Q1 2025 Earnings Call Transcript
- BeiGene: Q4 Results Impress With Positive Earnings Expected In 2025
- BeiGene, Ltd. (ONC) Q4 2024 Earnings Call Transcript
- BeiGene reports mixed Q1 results; reaffirms FY25 outlook
- Summit extends gains as cancer drug outperforms BeiGene’s Tevimbra